The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference
The use of recombinant human growth hormone to protect against muscle weakness in patients undergoing anterior cruciate ligament reconstruction: A pilot, randomized placebo-controlled trial
Testing & COA: Publishes independent third-party test results, so open the report for your specific batch before ordering
If you have a special diet (vegetarian, vegan, gluten-free), let us know in advance
Add-on value of tirzepatide versus semaglutide